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Abstract
Background: Post-abortion contraceptive use in India is low and the use of modern methods of contraception is
rare, especially in rural areas. This study primarily compares contraceptive use among women whose abortion
outcome was assessed in-clinic with women who assessed their abortion outcome at home, in a low-resource,
primary health care setting. Moreover, it investigates how background characteristics and abortion service provision
influences contraceptive use post-abortion.
Methods: A randomized controlled, non-inferiority, trial (RCT) compared clinic follow-up with home-assessment of
abortion outcome at 2 weeks post-abortion. Additionally, contraceptive-use at 3 months post-abortion was
investigated through a cross-sectional follow-up interview with a largely urban sub-sample of women from the RCT.
Women seeking abortion with a gestational age of up to 9 weeks and who agreed to a 2-week follow-up were
included (n = 731). Women with known contraindications to medical abortions, Hb < 85 mg/l and aged below 18
were excluded. Data were collected between April 2013 and August 2014 in six primary health-care clinics in
Rajasthan. A computerised random number generator created the randomisation sequence (1:1) in blocks of six.
Contraceptive use was measured at 2 weeks among women successfully followed-up (n = 623) and 3 months in the
sub-set of women who were included if they were recruited at one of the urban study sites, owned a phone and
agreed to a 3-month follow-up (n = 114).
Results: There were no differences between contraceptive use and continuation between study groups at
3 months (76 % clinic follow-up, 77 % home-assessment), however women in the clinic follow-up group were most
likely to adopt a contraceptive method at 2 weeks (62 ± 12 %), while women in the home-assessment group were
most likely to adopt a method after next menstruation (60 ± 13 %). Fifty-two per cent of women who initiated a
method at 2 weeks chose the 3-month injection or the copper intrauterine device. Only 4 % of women preferred
sterilization. Caste, educational attainment, or type of residence did not influence contraceptive use.
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Conclusions: Simplified follow-up after early medical abortion will not change women’s opportunities to access
contraception in a low-resource setting, if contraceptive services are provided as intra-abortion services as early as
on day one. Women’s postabortion contraceptive use at 3 months is unlikely to be affected by mode of followup
after medical abortion, also in a low-resource setting. Clinical guidelines need to encourage intra-abortion
contraception, offering the full spectrum of evidence-based methods, especially long-acting reversible methods.
Trial registration: Clinicaltrials.gov NCT01827995
Background
Family planning relies on simple technology and is the
most cost-effective and feasible way to avoid unintended
pregnancies [1]. Post-abortion contraception is an essen-
tial component of comprehensive abortion care [2] and
provides a window of opportunity to motivate women to
adopt contraception [3]. However, to successfully motiv-
ate women to initiate contraception they must be
provided with appropriate counseling and a range of
evidence-based contraceptive methods to choose from
[4]. Allowing women to play an active role in deciding
their preferred method and informing them about po-
tential side effects and health outcomes can motivate ad-
herence and continuation [5]. A study from Nepal
shows that a majority (56 %) of women initiated a
‘modern’ or ‘traditional’ contraceptive method post-
abortion, however, that discontinuation rates were
high and half had discontinued within 12 months.
Still, use of contraception was better and initiated
earlier among post-abortion women compared with
post-partum women [6].
There is a large unmet need for family planning
(21 %) in India, especially among rural women. Women
primarily rely on sterilization to limit the number of
children [7], while they use ‘traditional methods’ to
space between children [8, 9]. These findings can be ex-
plained by the persisting stigma attached to modern
contraception use, especially in rural areas, resulting in
young women’s fear of jeopardizing their social status if
they were to use modern contraception [9]. An Indian
national survey showed that 70 % of women who had
an abortion did not use contraception post-abortion
[10]. Conversely, in a study from two Indian states,
Jharkhand and Bihar, the majority of women adopted
contraception post-abortion when provided with com-
prehensive contraceptive counseling and a range of
methods [11]. The National rural health mission
(NRHM), the governmental effort to increase access to
equitable health care, offers condom, oral pill, copper
intrauterine device (IUD), and sterilization. Three-
month injections, implants and hormone IUD are not
covered by the government’s family planning scheme,
however, injectables can be purchased in most hospitals
or pharmacies [12] and there are ongoing discussions
to whether or not the injectable should be included
under the government family planning scheme. Abor-
tion is legal and the national abortion guidelines advo-
cate contraceptive counseling post-abortion and specify
the suitable post-abortion contraceptive methods avail-
able [13]. In spite of this, less than half of women
who received an abortion received post-abortion
contraceptive counseling in Rajasthan and Maharashtra
[14, 15].
Medical abortion is a non-surgical procedure similar
to a spontaneous abortion and is induced by the com-
bination of mifepristone, an anti-progesterone, and mi-
soprostol, a prostaglandin E1 analogue [16, 17]. There is
no clinical need for follow-up after a medical abor-
tion [2], however, it is important to exclude the risk
of ongoing pregnancies, and this can be resolved
through the use of a home-based self-assessment re-
gime [18, 19]. Published results from this randomized
controlled trial (RCT) found that women’s home-
assessment using a low-sensitivity pregnancy test
(LSPT) and a pictorial instruction sheet 2 weeks after
medical abortion is effective, acceptable and feasible
[18, 20]. The efficacy of abortion among women who
carried out home-assessment was non-inferior to
those who attended in-clinic follow-up, and thus sug-
gests the efficacy of simplified medical abortion in a
low-resource and rural setting where women’s educa-
tional attainment is low [18]. However, simplified
follow-up is not yet readily implemented and the
practice of clinic follow-up after medical abortion
persists in many settings. In India, women rarely re-
turn to the clinic for follow-up post-abortion, result-
ing in the health system’s lost opportunity to
determine the outcome of the abortion as well as to
provide post-abortion contraception [21]. While there
are advantages in allowing women to confirm medical
abortion outcome independently, without having to
return to the clinic [18, 20], a potential disadvantage
is that women will have decreased access to post-
abortion contraceptive services. However, little is
known about contraceptive use among women carry-
ing out most of their medical abortion at home, espe-
cially in low-resource settings. This study examines
whether there is evidence that such a disadvantage
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exists by comparing contraceptive use among women
whose abortion outcome was assessed in-clinic with
women who assessed their abortion outcome at
home, in a low-resource, primary health care setting.
Additionally, it investigates how background charac-




This study was a randomized controlled non-inferiority
trial with an additional 3-month cross-sectional follow-
up interview with a sub-set of women from the RCT.
The RCT compared clinic follow-up with home-
assessment at 2 weeks after early medical abortion in a
low-resource setting in Rajasthan, India. The 3-month
follow-up was carried out to monitor the use and con-
tinuation of methods, and to determine whether differ-
ent trends of contraceptive use could be established in
the two study groups. The RCT followed CONSORT
guideline format for non-inferiority randomised trials
[22]. The primary outcome of the RCT was to measure
the efficacy of home-assessment of women’s abortion
outcome. Contraceptive use was measured as a second-
ary outcome of the RCT and the primary outcome of the
cross-sectional sub-study. Details of the RCT implemen-
tation, setting and context, in addition to the methods,
are described in the study protocol [23]. Results related
to the efficacy of simplified follow-up after medical abor-
tion are reported elsewhere [18].
Study setting and participants
The RCT was conducted at six primary health care facil-
ities; three clinics situated in an interior rural area in the
Araveli mountain range, characterized by limited road
connections, poverty, and strong gender disparities; and
three clinics in Udaipur City. The rural clinics cater to
women belonging to a lower socio-economic stratum
and the area is largely populated by social groups that
are referred to as marginalized [7] and defined by the
government as scheduled castes (SC) and scheduled
tribes (ST). The urban clinics cater mainly to urban
women from all socio-economic strata. Women were
eligible to participate in the study: when seeking med-
ical abortion; with a pregnancy of up to 9 weeks of ges-
tation, as estimated by pelvic examination; if they
resided in an area where follow-up was possible or had
a phone of their own; and if they agreed to a follow-up
appointment 2 weeks after the abortion. For the 3-
month follow-up, women were included if they: owned
a phone; were recruited in the urban study sites; and
agreed to a telephonic follow-up at 3 months. Women with
known contraindications to medical abortion; who had a
haemoglobin value below 85 mg/l; or who were below 18
years of age were excluded.
Intervention and procedure
Before study recruitment, a doctor assessed all women
seeking abortion and identified the women who were
eligible, and who had opted for a medical abortion.
These women were counselled with regard to the abor-
tion procedure and were subsequently administered the
first dose, mifepristone (200 mg), in the clinic. All
women were counselled on contraception according to
clinical standard procedure in respective study site.
Additionally, the doctor and woman agreed on the lo-
cation of misoprostol administration together; this was
not randomized, but was based on the woman’s prefer-
ence and the doctor’s discretion. Subsequently, the
women who had been identified by the doctor as being
clinically eligible for the study met with a research as-
sistant, who explained the study and obtained informed
consent. Women who consented were randomly allo-
cated to either return to the clinic for follow-up by a
doctor (in-clinic follow-up group), or to assess their
abortion outcome at home using an LSPT and a pictor-
ial instruction sheet, and subsequently be followed-up
by a research assistant over the telephone or at home
(home-assessment group). Research assistants recorded
the women’s socio-demographic profile and reproduct-
ive history, including previous use of contraception.
Scheduled follow-up took place at 10–15 days after
mifepristone administration. Women were informed
that they could return to the clinic in case of any per-
ceived complications, however, the women in the
home-assessment group were advised to not return to
the clinic for the purpose of contraception before their
scheduled follow-up. This stipulation was made be-
cause interim visits would interfere with the home-
assessment intervention, unless they were returning to
the clinic due to complications or adverse events. The
study sites were instructed to provide contraceptive
counselling to all women, and to provide a suitable
method, when applicable, on day 1 and day 3 (for the
women who returned to the clinic for misoprostol ad-
ministration (n = 333)) of the medical abortion. The
women who returned to the clinic for misoprostol ad-
ministration on day three met a doctor or a nurse and
stayed in the clinic for 1–4 h depending on the study
site and the distance to the woman’s home. On this
day, the care provider completed the research question-
naire and recorded whether or not a contraceptive
method was provided and, if so, which method was
provided. However, no specific intervention or training
in contraceptive counselling for the purpose of the
study was given and when implementing and piloting
the intervention we realised that providers at the study
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sites were reluctant to provide injectables already on
day 1 or 3 due to fear of side-effects and increased
bleeding post-abortion. Most providers preferred to
provide the method at the time of follow-up, regardless
of our attempts to encourage them to provide the
method earlier. A maximum of three follow-up at-
tempts were made within 1 month after the abortion,
and women not found were considered lost to sched-
uled follow-up. However, these women were contacted
retrospectively to confirm their abortion outcome.
A doctor or a midwife assessed women in the clinic
follow-up group at follow-up, 10–15 days after mifepris-
tone administration and provided contraception upon
request. All women who returned to the clinic for
follow-up were reimbursed for their travel expenses. The
women in the home-assessment group were followed-up
by a research assistant over the telephone or at home
when the woman did not have a phone of her own, com-
monly the case among rural residents. Women were
asked about their LSPT result and pregnancy symptoms.
Additionally, the research assistant asked all women
questions relating to contraceptive preference, use and
intention, as well as about their abortion experience.
At the 2-week follow-up, women recruited to the
study in the urban sites, and who owned a phone of
their own, were asked to participate in the 3-month
follow-up interview. Women in the rural sites were not
considered for the 3-month cross-sectional survey due
to their lack of mobile phones and because it was not
considered feasible or appropriate to make another
home-visit. Three months after their abortion, the same
research assistant who met the women at 2 weeks tele-
phoned the women who had agreed to a follow-up ap-
pointment. A maximum of three attempts were made
before the women were considered lost to the 3-month
follow-up. Questions regarding contraceptive use, method
of initiation and time of initiation were asked. To facilitate
a method for the women to remember their time of
contraceptive initiation we asked whether contracep-
tion was initiated: immediately on day 1of the abortion;
after misoprostol on day 3; at the time of the follow-up
(2 weeks); at the time of the following menstruation
(around 4 weeks); recently, which refers to 1 month
previous to the 3-month follow-up (8 weeks); just now
(12 weeks); or not at all. We also asked whether the
woman had had any pregnancies or abortions in the
last 3 months. Standardized questionnaires were used
throughout the study.
Definitions
The study sites offered copper-IUD, 3-month injection,
oral pill and condom, which are referred to as modern
contraception for the purpose of this study. In the re-
sults section, the reversible contraceptive methods are
grouped into two groups: the injectable and copper-IUD
as one group, and the oral pill and condom as another
group. This is an attempt to categorise the methods
according to: methods with a more ‘long-acting and
user-independent nature’, although the injection is not
considered a LARC by the WHO; and methods with a
more ‘short-acting and user-dependent nature’. Add-
itionally, in contrast to IUD and injectables, women who
reported initiation of contraceptive pills or condoms at
the 2-week follow-up, may or may not actually use these
methods after administration, especially with regard to
condom use. Contraceptive use was defined as current
use or initiation at 2 weeks and 3 months. Contraceptive
initiation refers to the time when women started using
their contraception. Additionally, we asked questions re-
garding; contraceptive method of preference, and the
intention to initiate the method preferred at 2 weeks or
the reasons for not choosing a method. Women could
select several methods of preference, however for the
purpose of analysis of method preference and contracep-
tive counselling (Fig. 4), we chose to organise methods
of preference accordingly: women, who preferred either
injectable or IUD have been reported as preferring in-
jectable or IUD regardless of any additional preferences.
Women, who reported to prefer oral pill only responded
oral pill or condom; women, who reported to prefer
sterilization only responded sterilization or condom; and
women, who reported to prefer condom responded no
other method but condom. Intention to initiate was di-
vided into two categories: ‘actual plan’, defined as today,
this week, after recovered from abortion, and after next
menses; and ‘no actual plan’, defined as when my hus-
band moves back from the city, after next holiday, and
sometime next year.
Study outcomes and measures
The primary outcome of this study was women’s use of
modern contraception post-abortion, compared between
study groups, and measured at 2 weeks and at 3 months
after the medical abortion. Due to the small sample size
of women in the 3-month follow-up, these data were
used to indicate a trend of overall contraceptive use and
continuation. The contraceptive preference, choice and
usage patterns at 2 weeks in the sub-set of women
allowed us to compare patterns seen among the same
women in the 3-month follow-up, and in that way valid-
ate the 3-month data considering the small sample size
at the follow-up. Moreover, it allowed us to compare the
contraceptive patterns found in the sub-set of women
with the patterns in the total study population at
2 weeks and hence indicate a trend of overall contra-
ceptive use at 3 months, while being aware of the
socio-economic differences between the sub-sample
population and the whole study population. Secondary
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outcomes included: women’s preferred contraceptive
method; whether women had initiated their preferred
method at the time of follow-up (2 weeks and
3 months); and if not, whether their intentions to initi-
ate were according to an ‘actual plan’ or ‘no actual plan’
(as defined above). Moreover, associations between
contraceptive use at 2 weeks and 3 months; and
women’s socio-demographic and reproductive back-
ground; contraceptive counselling; time of provision of
the contraceptive method; contraceptive intention at
2 weeks; and abortion experience in terms of satisfac-
tion, were assessed.
Randomisation and masking
Block randomisation, using blocks of six, was used and
a computerised random number generator (Random
Allocation Software 2.0) generated the randomisation
list [18]. The staff who generated the list and prepared
the opaque sealed envelopes used for randomisation were
not involved in data collection. Details of the randomisa-
tion procedure are recorded in the study protocol [23].
Statistical methods and analysis
All statistical calculations were made using SPSS (ver-
sion 20) and R (version 3.0.3). Descriptive statistics are
presented for all variables. Categorical variables are com-
pared using χ2-test or Fisher’s exact test when appropri-
ate. Continuous data are presented as mean (range). A
p-value below 0.05 and a 95 % confidence interval (95 %
CI), presented as ±, demonstrate significant differences.
Odds ratios (ORs) were derived using logistic regression
with various explanatory variables. Where related ORs
were significant, adjusted odds ratios (AORs) were de-
rived with multivariate logistic regression. Use of
contraception over time was illustrated by conducting
Kaplan-Meier survival analysis where a log-rank test
established significance.
Analyses were carried out for evaluable subjects (ES):
all women with a successful scheduled follow-up at
2 weeks, regardless of whether their abortion was
complete or whether they had taken the full course of
the medical abortion or not. To compensate for differ-
ence in loss to scheduled follow-up between the study
groups, the outcome of whether a woman had initiated
contraception was analysed using intention to treat
(ITT) analysis, including all women who were random-
ized to one of the study groups, assuming that none of
the women who were lost to scheduled follow-up had
initiated a method at 2 weeks, except where data for
contraceptive provision on day three were available. All
women who had a successful 3-month follow-up were
included in the sub-set analysis.
The study was developed and coordinated by Karolinska
Institutet, and Uppsala University, Sweden, and Action
Research and Training for Health (ARTH), Udaipur,
India. The trial was registered at Clinicaltrials.gov:
NCT01827995. The Institutional Ethics Committees at
ARTH, and the Health Ministry’s Steering Committee
of Government of India approved the study.
Results
A total of 957 women sought abortions and were
screened for study eligibility during the study recruit-
ment (April 2013 – June 2014); of these, 731 consented
to participate and were randomized to either the in-
clinic follow-up group (n = 353) or the home-assessment
group (n = 378), and were included in the ITT analysis.
In total, 626 women had a scheduled follow-up at
2 weeks and were included in ES analysis, and 114
women were successfully telephoned at 3 months, all of
whom were included in the ES population, except one
woman who was lost to scheduled follow-up at 2 weeks.
The last follow-up was conducted in August 2014. The
flow of patients is visualized in Fig. 1 and the participant
profile is summarized in Table 1.
Contraceptive use at 2 weeks and 3 months compared
between study groups (n = 114)
Most women (83 ± 6.9 %) had adopted and were still
using (76 ± 7.8 %) a contraceptive method at 3 months
post medical abortion, regardless of study group alloca-
tion (Fig. 2). There was no significant difference in
contraceptive use between the study groups at the 2-
week follow-up among the sub-set of women; however,
there was a clear trend of increased use in the in-clinic
follow-up group (Fig. 2). While women in the in-clinic
follow-up group (n = 62) were most likely to initiate
contraception at follow-up (62 ± 12 %), women in the
home-assessment group (n = 52) were most likely to ini-
tiate contraception after next menstruation (60 ± 13 %).
The trend of contraception initiation over time was ana-
lyzed with Kaplan-Meier Survival Analysis, illustrated in
Fig. 3, where an event is defined as contraceptive initi-
ation and the curve shows the non-initiation of contra-
ception. Methods initiated at 3 months varied. Condom
or oral pill were the methods that were mostly used,
with no difference between study groups. However, 21 %
(n = 11) of women in the in-clinic follow-up group had
initiated the injectable or the copper-IUD compared
with 10 % (n = 4) of the women in the home-assessment
group. Three women had undergone sterilization (data
not shown).
Contraceptive use at 2 weeks compared between study
groups (n = 626)
We analyzed contraceptive use at 2 weeks post-abortion
in the ES population of the RCT (n = 626) (Table 2).
Most women (89 %) intended to start a specific
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contraceptive method with no difference between study
groups. Of those, 81 % opted for the oral pill, the 3-
month injection or the copper-IUD, with no difference
between the study groups. Overall, 33 % of ES popula-
tion had initiated a method at scheduled follow-up.
However, the question was only asked to women who
had chosen a method of preference at follow-up (n =
556), and among these, 37 % had initiated a method,
with a significant difference between study groups (clinic
follow-up group 53 ± 6.2 %, and home-assessment group
25 ± 4.8 %) (Table 2). The ITT analysis (n = 731), where
‘no contraceptive use’ was imputed for women who were
lost to scheduled follow-up and who did not initiate
contraception on day one or three, reveals a smaller, yet
significant difference between the study groups in terms
of contraceptive use at 2 weeks (38 ± 3.5 % clinic follow-
up group and 20 ± 2.9 % home-assessment group).
Among the women who had an intention to initiate a
specific method, but who had not yet initiated it at
scheduled follow-up (n = 348), most (85 %) had an ‘ac-
tual plan’ to initiate, with no difference between study
groups. For the women who did not wish to use any
method (n = 67), reasons such as fear of side-effects
(27 %), not cohabiting with their partner (20 %), not be-
ing aware of suitable methods (20 %) or lack of family
support (14 %) were given (data not shown).
Among the women in the ES population who reported
a preferred method (n = 556), significantly more women
opted for condom in the clinic follow-up group (23 %)
compared with the home-assessment group (16 %) (p =
0.025). Fewer women in the clinic follow-up group
opted for the 3-month injection (44 %) compared with
the home-assessment group (52 %) (p = 0.090). Only a
small proportion of women (4 %) desired sterilization.
Among all women who reported contraceptive use (n =
207), 52 % used the injectable (n = 95) or a copper-IUD
(n = 13) with no difference found between the study
groups (Table 3).
The influence of women’s background characteristics on
contraceptive use
Social group (caste), educational attainment, and place
of residence did not influence contraceptive use at
2 weeks or 3 months (data not shown). However, age
was influential and more women aged 25–29 years had
initiated a method at 2 weeks (38 %), compared with
women aged 20–24 and 30–35 years (28 and 26 %). Few
women (2 %) below 20 or above 35 had initiated a
method at 2 weeks (data not shown).
When adjusting for number of children (non-signifi-
cant), women were more likely (AOR 1.8, 95 % CI 1.0–
3.0) to report contraception use at 2 weeks if they had a
boy. Women with the intention to limit number of chil-
dren were more likely (OR 1.8 95 % CI 1.1–3.0) to have
chosen a method of preference, compared with women
who wanted to space. Women’s previous use of contra-
ception (n = 218) positively influenced contraception use
at 2 weeks (OR 1.4 95 % CI 1.0–2.0) and having had a
Fig. 1 Study flow diagram. Flow diagram of the RCT showing enrolment, allocation to home-assessment (n = 378) or clinic follow-up (n = 353)
group, the 2-week follow-up and analysis followed by the 3-month follow-up and analysis (n = 114)
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previous induced abortion (n = 212) was associated with
having an ‘actual plan’ to initiate contraception as re-
ported at the 2-week follow-up (OR 2.8 95 % CI: 1.3–
5.9) (data not shown).
Influential factors on contraceptive use
Most women (86 ± 2.7 %) reported having received
contraceptive counseling during their abortion, with no
significant difference between study groups (90 ± 3.6 %
in the clinic follow-up group and 83 ± 3.9 % in the
home-assessment group). Ninety percent of the women,
who received contraceptive counseling preferred a mod-
ern contraceptive method and 76 % preferred the
injectable or copper-IUD, 14 % preferred the oral pill or
condom and two women preferred sterilization (Fig. 4).
These results were significantly (p < 0.001) different to
those for women who reported no contraceptive coun-
seling, where only 63 % preferred any method, of these,
49 % preferred either the injectable or copper-IUD and
14 % preferred the oral pill or condom (Fig. 4). Contra-
ceptive counseling was associated with three times
higher odds (AOR 3.4 95 % CI 1.5–7.8) of having re-
ported contraception use at 2 weeks, when adjusted for
contraceptive method provision on day three. Moreover,
women who were provided with a contraceptive method
on day three of the abortion were four times (AOR 3.7
Table 1 Women’s socio-demographic and reproductive profile stratified by group allocation and 3-month follow-up










Median age, years (range) 27 (18–48) 27 (18–46) 27 (18–48) 27 (18–43)
Residency, n (%)
- Urban 92 (34) 94 (27) 186 (30) 101 (89)
- Rural 182 (66) 258 (73) 440 (70) 13 (11)
Belong to SC/ST Caste, n (%) 141 (51) 200 (57) 341 (55) 24 (21)
Level of Education, n (%)
- No formal 124 (45) 202 (57) 326 (52) 10 (9)
- Primary (1–3 years) 51 (19) 49 (14) 100 (16) 11 (10)
- Secondary (4–10 years) 61 (22) 57 (16) 118 (19) 45 (39)
- Higher (>10 years) 38 (14) 44 (13) 82 (13) 48 (42)
Ownership of phone
- Woman herself 130 (47) 155 (44) 285 (46) 114 (100)
- Husband 100 (36) 133 (38) 233 (37)
- No/others 44 (16) 64 (18) 108 (17)
Primigravida, n (%) 10 (4) 18 (5) 28 (5) 7 (6)
One or more living girlsa 184 (70) 238 (71) 422 (71) 66 (62)
One or more living boysa 220 (84) 276 (83) 496 (83) 79 (74)
Median gestational age, weeks (range) 6.6 (5–9) 6.6 (5–9) 6.6 (5–9) 6.1 (5–9)
- Gestational age in weeks, n (%)
< 6 weeks 51 (19) 59 (17) 110 (18) 27 (24)
6–7 150 (55) 197 (56) 347 (55) 73 (64)
> 7 weeks 73 (27) 96 (27) 169 (27) 14 (12)
Prior elective abortion, n (%) 106 (39) 106 (30) 212 (34) 55 (48)
- Medicalb 79 (75) 85 (80) 164 (77) 46 (84)
- Surgicalb 30 (28) 26 (25) 56 (26) 18 (33)
Home administration of misoprostol, n (%) 134 (49) 156 (44) 290 (46) 67 (59)
Ever-used modern contraception, n (%) 111 (41) 107 (30) 218 (35) 78 (68)
*The women in the 3-month FU are included in the ES population
aPresented as percentage of women with children (n = 264 in clinic FU and n = 336 in home-assessment)
bPresented as percentage of women with prior elective abortions (n = 106 in clinic FU and n = 106 in home-assessment)
There are no significant differences between the study groups within the ES population
There were no socio-demographic background differences between the women included in analysis and the women who were lost to follow-up (data of women
lost to follow-up is not shown)
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95 % CI 2.0–6.9) more likely to have initiated contracep-
tion at 2 weeks compared with the women who did not
receive or initiate a contraceptive method on day three
when adjusting for women’s reported contraceptive
counseling (data not shown). Moreover, being satisfied
with the abortion positively influenced whether women
chose a method at 2 weeks or not (OR 3.5 95 % CI 1.4–
8.7) and having chosen a method and reporting an ‘ac-
tual plan’ to initiate at 2 weeks was associated with a
six-times increased odds of contraception use at
3 months (OR 5.9 95 % CI: 1.2–28.4) (data not shown).
Discussion
Our study shows that there is no difference in contra-
ceptive use 3 months post-abortion among women
whose abortion outcome was assessed in-clinic com-
pared with women who assessed their abortion at home,
bearing in mind that women in the 3-month follow-up
Fig. 2 Comparing Contraceptive Status at 2 weeks and 3 months among the sub-set of women (n = 114). Left side: Women’s contraceptive status
at 2 weeks: contraceptive use, whether has an ‘actual plan’ to use contraception, whether opted for a preferred method. Women were included if
followed-up at 3 months (n = 114). Right side: Women’s contraceptive status at 3 months: contraceptive use and continuation, whether planning
to start, discontinuation, and no plan to use contraception (n = 114)
Fig. 3 Contraceptive use over time (n = 114). Kaplan-Meier Survival Curve of contraceptive use over 3 months (12 weeks) as reported by the women
where 2-weeks was at follow-up, 4 weeks represent after next menses, 8 weeks 1 month prior to 3-month follow-up, and 12 weeks refer to around the
time of the phone-call. 1 event = contraception initiated. Stratified by treatment group (n = 114)
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mainly resided in urban areas where health care is easier
to access. The post-abortion contraceptive use at
3 months seen in our study corresponded with results
from previous studies in similar settings [11]. Interest-
ingly, at the 2 week follow-up we found a higher overall
contraceptive use (33 %) after medical abortion than was
previously seen in similar settings in India (9 %) [10, 11].
This was true regardless of study group allocation and in
spite of that most of the study participants in the RCT
belonged to disadvantaged social groups and where the
majority of participants resided in rural areas. However,
there was a difference in method use between study
groups. A larger proportion of women (53 %) in the
clinic follow-up group had initiated contraception in
comparison with women in the home-assessment group
(25 %). A Nordic RCT investigating home-assessment
post-medical abortion indicated higher (55 %) overall
use 2 weeks post-abortion than was seen in our study,
and with no difference between the study groups [19]. In
spite of the Nordic setting being different from our study
setting, our findings from the 3-month follow-up and
the Nordic RCT suggest that with comprehensive
contraceptive counseling and available contraception,
women may be motivated to initiate contraception post-
abortion irrespective of location of outcome assessment
in both high- and low-resource settings. Even though
the 3-month follow-up was carried out among women,
who were mostly residing in urban areas, it is important
to highlight that most study participants belong to
underprivileged social groups with a relatively low socio-
economic status, with women recruited at the rural sites
having the lowest status. Our study shows that the
contraceptive intentions reported by women at 2 weeks
in the sub-set of women and in the total study popula-
tion are comparable. Moreover we show that social
group, educational attainment and residency do not
affect women’s contraceptive use. Based on this we sug-
gest that the observed 3-month contraceptive use in the
sub-set of women can be used to indicate an overall
trend of contraceptive use at 3 months in general, bear-
ing in mind that the women in the sub-set had a slightly
higher socio-economic status and resided in urban areas
where health care is easier to access. The slightly post-
poned use of contraception among the home-assessment
women is similar to what was previously observed when
comparing contraceptive use after medical versus surgi-
cal abortion [11]. Thus, the delay in our study may be
an effect of sub-optimal contraceptive counseling and
provision rather than the course of abortion, whether
home- or clinic-based.
To optimize contraceptive provision in medical abor-
tion we need to understand what factors contribute to
contraception use in low-resource settings. The WHO
safe abortion guidelines state that contraceptive counsel-
ing must be provided on day one of abortion, and that
most contraceptive methods are feasible to initiate on
day one or three of the medical abortion [2]. Our study
enforces this statement by showing that contraceptive
Table 2 Women’s contraceptive use and intention at 2-week
follow-up (n = 626)
Clinic FU
n (% ± 95 % CI)
Home-assessment
n (% ± 95 % CI)
Total
n (% ± 95 % CI)
p-value
Preferred method for initiation chosen (n = 626)
Yes 250 (92 ± 3.2) 306 (87 ± 3.5) 556 (89 ± 2.44) 0.059
No 22 (8 ± 3.2) 45 (13 ± 3.5) 67 (11 ± 2.44)
Method initiated at 2 weeks (n = 556)
Yes 133 (53 ± 6.2) 75 (25 ± 4.8) 208 (37 ± 4.0) <0.001
No 117 (47 ± 6.2) 231 (76 ± 4.8) 348 (63 ± 4.0)
Actual plan to initiate method at 2 weeks (n = 348)
Yes 104 (89 ± 5.7) 192 (83 ± 4.8) 296 (85 ± 3.7) 0.154
No 13 (11 ± 5.7) 39 (17 ± 4.8) 52 (15 ± 3.7)
Significant differences are indicated by p < 0.050. Missing values were
excluded from analysis. Percentages are presented as column percentages.
Actual plan to initiate was defined as: ‘after next menstruation’, ‘within 1 week’,
‘when recovered from abortion’
Table 3 Contraceptive method at 2 weeks stratified by study group: preferred and initiated
Clinic FU Home-assessment Total p-value
Method preferred (n = 556)
Condom 58 (23 %) 48 (16 %) 106 (19 %) 0.025
Oral pill 61 (24 %) 62 (20 %) 123 (22 %) 0.242
Copper-IUD 30 (12 %) 37 (12 %) 67 (12 %) 0.974
3-month injection 111 (44 %) 158 (52 %) 269 (48 %) 0.090
Sterilization 6 (2 %) 18 (6 %) 24 (4 %) 0.044
Method initiated (n = 207)
IUD or injectablea 73 (55 %) 35 (47 %) 108 (52 %) 0.295
Oral Pill/Condom 60 (45 %) 39 (53 %) 99 /48 %) 0.295
Method preferred refers to women who chose a method for initiation at 2 weeks however did not necessarily initiate it at 2 weeks (n = 556). While method
initiated refers to the women who reported to have started at 2 weeks (n = 207)
aIUD refers to Copper Intra-uterine device (IUD) and injectable to the 3-month injection
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counseling on day one, provision of a method on day
three, and having an actual plan to initiate on day 14
were associated with contraceptive use at 2 weeks and
3 months. In line with this finding, previous research
shows that having a reproductive intention, with regard
to spacing or limiting childbearing, motivates women
to adopt contraception [18]. We believe that effective
provision of intra-abortion contraception could circum-
vent much of the decreased use at 2 weeks that was seen
in the home-assessment group in our study, because
there were no differences in the women’s intentions to
initiate contraception between the study groups.
Women in our study preferred reversible or barrier
methods and rarely desired sterilization. This finding is
in sharp contrast to the widespread use of female
sterilization, representing two-thirds of contraceptive
use in India [24]. Interestingly, the 3-month injection
was the overall preferred method, especially among the
rural residents, supporting a trend documented in re-
cent studies from similar settings [6, 12], and arguing
for the inclusion of the 3-month injection under the
NRHM family planning initiative. Additionally, hormonal
IUDs and implants should be included as contraceptive
options, given their long-acting nature, to avoid discon-
tinuation soon after initiation [25, 26]. Such methods may
also be preferable for the women because their use could
be kept secret from other family and community mem-
bers, and hence increases the feasibility of using the
method [9]. Similarly, it has been argued that women in
situations of dependence are more likely to avoid jeopard-
izing their social relationships, in this case by using
contraception, to avoid the risk of rejection and loss of
support [27]. Another study showed that Nepali women
who received condom and oral pill post-abortion were
more likely to discontinue within 12 months [28], sup-
porting the importance of focusing on long-acting revers-
ible contraceptive methods. In the total study population,
women in the in-clinic follow-up group were more likely
to prefer condoms at 2 weeks. This finding may be attrib-
uted to the patient-provider power-dynamic, putting
women in a vulnerable position where they do not want
to disobey the provider who is offering contraception,
combined with women’s lack of autonomy resulting in
their unlikeliness to act on their own preference [29]. This
indicates the importance of empowering women to choose
their method of preference from a range of different
Fig. 4 Contraceptive Counseling and Preference of Method (n = 626). Type of contraceptive method preferred by the woman stratified by
whether the woman reported to have received contraceptive counselling nor not. Methods are categorized into injectable and IUD, Condom
and Oral Pill, and sterilization. Women could choose to prefer more than one method, however for the purpose of analysis only one preferred
method per woman is illustrated
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methods as well as encouraging them to return to the
clinic if they want to discontinue or switch methods. In
line with previous studies [6, 30, 31], our study showed
that a woman’s age, existing family size, and whether the
woman had any sons influenced contraceptive use. This
supports the persisting misconceptions and fear of infertil-
ity related to contraceptive use. However, with the ob-
served changes in the childbearing norms in India, young
women living in rural areas have new opportunities to ne-
gotiate their reproduction [9]. The young women’s self-
identified need for effective contraception, and their wish
to space between and limit the number of children, pro-
vides the health care system with an excellent opportunity
to motivate and increase women’s adoption of modern
contraception [9].
Our study emphasized the importance of effectively of-
fering contraception with a focus on the 3-month injec-
tion, the copper-IUD and other LARCs, intra-abortion.
Early initiation of contraception is crucial to avoid repeat
unintended pregnancies. Research shows a rapid return
of ovulation post-abortion and most women ovulate be-
fore returned menses, however, ovulation may occur as
early as 10 days post-abortion [32]. Hence, to wait to ini-
tiate contraception beyond 10 days post-abortion puts
women at risk of unintended pregnancies, however, in-
creasingly so if contraceptive provision is postponed
until after the next menses [32]. Most LARCs and the 3-
month injection, can be initiated on the same day as
misoprostol, or after the confirmed expulsion of the
pregnancy [33, 34]. Moreover, early insertion of hormo-
nal IUD reduces the number of days of heavy bleeding
post-abortion [34], which is beneficial in settings where
anemia is common [35]. In line with these findings,
Nepali women who adopted LARC post-abortion were
less likely to discontinue or experience unplanned preg-
nancies within 1 year [6, 28]. Unfortunately, copper-
IUDs or injectables were rarely provided on day three of
the abortion in our study, primarily due to lack of rou-
tine and providers’ reluctance to do so. This can partly
explain the lesser use of these methods in the home-
assessment group at 2 weeks, and 3 months. However,
the difference in use of IUD and injectables at 3 months
must be further investigated to understand how to facili-
tate women’s initiation of long-acting methods, if they
assess their abortion outcome at home, particularly be-
cause more women in the home-assessment group had
expressed their preference towards the IUD or the in-
jectable at the 2-week follow-up compared with women
in the in-clinic follow-up group. Moreover, providers’ at-
titudes to and knowledge of contraceptive services are
crucial for the provision of contraception. A study of In-
dian medical students identified that they possessed poor
knowledge and had misconceptions with regard to mod-
ern contraception [36]. Hence, more research and clear
clinical guidelines are required to support health care
providers in their provision of contraceptive methods in
medical abortion, especially with regard to early initi-
ation of LARCs and the 3-month injection. In-service
training of contraception in abortion care is crucial and
should be combined with training in ‘simplified early
medical abortion’ as this has proven to be effective and
acceptable in low-resource settings [18, 20, 37].
To our knowledge, no previous RCT has investigated
contraceptive use post-simplified-follow-up after medical
abortion in a low-resource setting. However, there is a
need for research on rural women’s contraceptive use
and continuation over time as well as a more extensive
study on urban women’s contraceptive use over time
due to the small sample size in our study. Moreover,
studies should preferably investigate contraceptive use
over a longer time period than 3 months post-abortion.
Another limitation of our study was that women in the
home-assessment group could not return to the clinic
for contraceptive initiation before their scheduled
follow-up. This may have resulted in fewer women
reporting contraceptive use by the time of their follow-
up appointment, and may have affected the difference in
contraceptive use between study groups. Moreover,
women in the clinic follow-up group were reimbursed
for their travel costs to decrease the dropout rate [23].
This encouraged women to return to the clinic and of-
fered a better opportunity for contraception provision
than is commonly seen [21]. These scenarios could have
been circumvented by the provision of contraception on
day one or three; however, this was not the clinical prac-
tice in most of the study sites. Finally, the risk of recall
bias must be taken into account. At the 2-week follow-up,
women were asked whether they had received contracep-
tive counseling on day one, and whether or not they had
initiated a method before the 2-week follow-up. One can
argue that women who had initiated a method were more
motivated to report that they had received counseling,
however, judging from the data and that most women re-
ported contraceptive counseling regardless of contracep-
tive use at 2-weeks, indicates the validity of our findings.
Moreover, if necessary, the research assistant could care-
fully probe for information about different aspects of
the contraceptive counseling session, such as whether the
woman remembered that the doctor spoke of methods to
avoid pregnancy, this was to help the woman remember
the encounter. However, and more importantly, for the
women who were followed-up after 3 months, we asked
when they had initiated the method of contraception. To
facilitate these responses, the research assistant referred to
actual events, such as ‘at follow-up’, ‘after next menstru-
ation’ etc., rather than asking for time intervals in weeks.
These events were then translated into number of weeks
for the purpose of the survival analysis.
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Conclusion
Simplified follow-up after early medical abortion will
not change women’s opportunities to access contracep-
tion in a low-resource setting, if contraceptive services
are provided as intra-abortion services as early as on
day one. Women’s post-abortion contraceptive use at
3 months is unlikely to be affected by mode of follow-
up after medical abortion, also in a low-resource
setting. Allowing women the choice of follow-up may
motivate the use of LARCs or the 3-month injection.
However, to optimize contraceptive counseling and
provision in abortion care, all women should be offered
a range of evidence-based contraceptive methods as
early as on day one of their medical abortion, regardless
of age or parity.
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